Developing radionuclide PARP inhibitors
Interviewee/Contributor
Greg Mullen
Organisation
Theragnostics Ltd
Personalised medicine
A diagnostic test that identifies the correct treatment for a particular individual
Detecting cancer using liquid biopsy
Interviewee/Contributor
John Beeler and Andrew Newland
The power of numbers in genomics research
Interviewee/Contributor
Rob Brainin
Organisation
Illumina Inc
Liquid biopsy comes of age
Interviewee/Contributor
Robin Davison
Organisation
New Science Global Healthcare Fund
Precision Medicine: Interview with Molecular Health GmbH
Interviewee/Contributor
Friedrich von Bohlen
Organisation
Molecular Health GmbH
Precision Medicine: The challenge of using big data to help patients
Interviewee/Contributor
Ruth March
Organisation
AstraZeneca Plc
Genomic Research - What IP filings show about the major players
Interviewee/Contributor
Florian Bazant-Hegemark
Organisation
Marks & Clerk LLP
Targeting new medicines at Roche
Interviewee/Contributor
Max Hasmann
Organisation
Roche Group
How induced pluripotent stem cells are becoming a tool for personalised medicine
Interviewee/Contributor
Chris Parker
Organisation
Cellular Dynamics International
Update on Personalised Medicine
Interviewee/Contributor
Victoria English
Organisation
MedNous